Comparison of 6-Month and Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Biodegradable Polymer Everolimus-Eluting Stent.
Yong-Hoon YoonGyung-Min ParkJae-Hyung RohSung-Ho HerSeong-Hoon LimTae Soo KangSeung Jin LeeJang-Whan BaeWoongGil ChoiYong-Mo YangJunghee KimYu Jeong ChoiSi Wan ChoiJae Hwan LeePublished in: Cardiology research and practice (2022)
In real-world patients undergoing PCI with BP-EES, the ischemic and bleeding endpoints demonstrated no difference between 6-month and prolonged (>6 months) DAPT.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- patients undergoing
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- atrial fibrillation
- coronary artery bypass grafting
- drug delivery
- coronary artery bypass
- ischemia reperfusion injury
- heart failure
- brain injury
- left ventricular